Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Substance derived from the distillation of the bark of the camphor tree. Today it is synthesized from turpentine. It is used as a local anti-inflammatory for the skin in creams and lotions. There is no evidence of its decongestive or expectorant effect in preparations for inhalation and there is evidence of its toxicity. Topical cutaneous, oral or nasal administration.
At the date of the last update we found no published data on its excretion in breast milk.
Camphor is a very lipophilic substance that is very well absorbed by any route of administration (cutaneous, inhalation, oral...) crossing well the cell membranes. (Zuccarini 2009).
Its pharmacokinetic data make it likely to pass into milk in quantities that could be significant.
Camphor is neurotoxic and hepatotoxic (Bunchorntavakul 2013, Chitturi 2008), even in small doses and by cutaneous topical route, especially in children, causing headache, vomiting, convulsions and coma. (Nchinech 2019, Michiels 2010, Khine 2009, Zuccarini 2009, Guilbert 2007, Manoguerra 2006, Love 2004, Burkhard 1999, Gouin 1996, Theis 1995, Liebelt 1993, Joly 1980)
It should never be administered orally. It is not a suitable product for use during breastfeeding and in any case it should not be applied on the mother's breast as serious intoxications have occurred in children with small quantities ingested or applied in the nostrils.
If used during breastfeeding, to minimize exposure it may be advisable to wait 5 half-lives (T ½ ), about 10 hours after ingestion or application of a dose of camphor before resuming breastfeeding.